| Financial Year |
March 31 2020 |
| Monetary Funds |
1,032,497,911.37 |
| Held-for-trading Financial Assets |
157,673,128.55 |
| Notes Receivable |
-- |
| Accounts Receivable |
73,829,427.66 |
| Advances to Suppliers |
15,946,960.17 |
| Other Receivables |
13,895,856.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
54,696.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
209,000.00 |
| Other Current Assets |
5,555,377.14 |
| Total Current Assets |
1,299,662,357.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
143,224,681.62 |
| Fixed Assetes |
19,736,396.94 |
| Under-construction Projects |
1,468,034.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,726,665.14 |
| R&D expenses |
-- |
| Goodwill |
297,113,710.39 |
| Long-Term Deferred and Prepaid Expenses |
4,215,567.91 |
| Deferred Income Tax Assets |
221,402.55 |
| Other Non-Current Assets |
798,489.16 |
| Sub-Total of Non-Current Assets |
582,333,806.41 |
| Total Assets |
1,881,996,164.07 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
153,192,477.17 |
| Accounts Received In Advance |
8,219,925.64 |
| Employee Compensation Payable |
2,188,286.25 |
| Taxes Payable |
8,776,385.62 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
36,200,217.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
356,932,724.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
88,828,902.03 |
| Deferred Income Tax Liabilities |
1,871,907.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
91,650,810.46 |
| Total Liabilities |
448,583,534.64 |
| Paid-In Capital(Or Share Stock) |
1,987,700,000.00 |
| Capital Surplus |
1,145,307,255.90 |
| Surplus Reserve |
35,061,708.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,786,109,103.20 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,433,412,629.43 |
| Owner's Equity（Stockholder's Equity） |
1,433,412,629.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,881,996,164.07 |
